Zobrazeno 1 - 10
of 5 315
pro vyhledávání: '"Wennerberg K"'
Autor:
Ianevski A; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., Nader K; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., Driva K; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Senkowski W; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Bulanova D; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Moyano-Galceran L; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Ruokoranta T; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Kuusanmäki H; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Foundation for the Finnish Cancer Institute (FCI), Helsinki, Finland., Ikonen N; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., Sergeev P; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., Vähä-Koskela M; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., Giri AK; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Foundation for the Finnish Cancer Institute (FCI), Helsinki, Finland., Vähärautio A; Foundation for the Finnish Cancer Institute (FCI), Helsinki, Finland.; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Kontro M; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Foundation for the Finnish Cancer Institute (FCI), Helsinki, Finland., Porkka K; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Pitkänen E; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Heckman CA; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Wennerberg K; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Aittokallio T; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland. tero.aittokallio@helsinki.fi.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. tero.aittokallio@helsinki.fi.; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway. tero.aittokallio@helsinki.fi.; Oslo Centre for Biostatistics and Epidemiology (OCBE), Faculty of Medicine, University of Oslo, Oslo, Norway. tero.aittokallio@helsinki.fi.
Publikováno v:
Nature communications [Nat Commun] 2024 Oct 03; Vol. 15 (1), pp. 8579. Date of Electronic Publication: 2024 Oct 03.
Autor:
Tambe M; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Unterberger S; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Kriegbaum MC; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Vänttinen I; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Olgac EJ; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Vähä-Koskela M; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Kontro M; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Department of Hematology, Helsinki University Central Hospital Comprehensive Cancer Center, Helsinki, Finland.; Foundation for the Finnish Cancer Institute, Helsinki, Finland., Wennerberg K; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark. krister.wennerberg@bric.ku.dk., Heckman CA; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland. caroline.heckman@helsinki.fi.
Publikováno v:
Cell death & disease [Cell Death Dis] 2024 Oct 16; Vol. 15 (10), pp. 750. Date of Electronic Publication: 2024 Oct 16.
Autor:
Kytölä S; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Vänttinen IM; University of Helsinki, Helsinki, Finland., Ruokoranta T; Institute of Molecular Medicine Finland (FIMM), Helsinki, Finland., Partanen A; Kuopio University Hospital, Kuopio, Finland., Holopainen A; Kuopio University Hospital, Kuopio, Finland., Saad J; University of Helsinki, Helsinki, Finland., Kuusisto MEL; University of Oulu and Oulu University Hospital, Oulu, Finland, Oulu, Finland., Koskela S; Finland., Räty RK; HUS Helsinki University Central Hospital, Helsinki, Finland., Itälä-Remes M; Turku University Hospital, Turku, Finland., Västrik I; Institute of Molecular Medicine Finland (FIMM), Helsinki, Finland., Suvela M; University of Helsinki, Helsinki, Finland., Parsons AO; University of Helsinki, Helsinki, Finland., Porkka K; Helsinki University Central Hospital Comprehensive Cancer Center, Helsinki, Finland., Wennerberg K; University of Copenhagen, Copenhagen N, Denmark., Heckman CA; University of Helsinki, Helsinki, Finland., Jalkanen T; Estimates Ltd, Turku, Finland., Huttunen T; Estimates Ltd, Turku, Finland., Ettala P MD; Turku University Hospital, Turku, Finland., Rimpiläinen J; Tampere University Hospital, Tampere, Finland., Siitonen T; Oulu University Hospital, Oulu, Finland., Pyörälä M; Kuopio University Hospital, Kuopio, Finland., Kuusanmäki H; Institute of Molecular Medicine Finland (FIMM), Helsinki, Finland., Kontro M; Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Publikováno v:
Blood [Blood] 2024 Oct 02. Date of Electronic Publication: 2024 Oct 02.
Autor:
Avenel ICN; Department of Pathology, Bartholin Institute, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Ewald JD; Department of Pathology, Odense University Hospital, Odense, Denmark.; Pathology Research Unit, Department of Clinical Research, University of Southern Denmark Odense, Odense, Denmark., Ariey-Bonnet J; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; DCCC Brain Tumor Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Kristensen IH; Department of Pathology, Bartholin Institute, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Petterson SA; Department of Pathology, Odense University Hospital, Odense, Denmark.; Clinical Genome Center, Department of Clinical Research, University of Southern Denmark Odense, Odense, Denmark., Thesbjerg MN; Clinical Genome Center, Department of Clinical Research, University of Southern Denmark Odense, Odense, Denmark., Burton M; Clinical Genome Center, Department of Clinical Research, University of Southern Denmark Odense, Odense, Denmark., Thomassen M; Clinical Genome Center, Department of Clinical Research, University of Southern Denmark Odense, Odense, Denmark., Wennerberg K; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; DCCC Brain Tumor Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Michaelsen SR; Department of Pathology, Bartholin Institute, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; DCCC Brain Tumor Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Kristensen BW; Department of Pathology, Bartholin Institute, Rigshospitalet, Copenhagen, Denmark. bjarne.winther.kristensen.01@regionh.dk.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. bjarne.winther.kristensen.01@regionh.dk.; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark. bjarne.winther.kristensen.01@regionh.dk.; DCCC Brain Tumor Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. bjarne.winther.kristensen.01@regionh.dk.
Publikováno v:
Scientific reports [Sci Rep] 2024 Jul 31; Vol. 14 (1), pp. 17639. Date of Electronic Publication: 2024 Jul 31.
Autor:
Klomp JA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Klomp JE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Stalnecker CA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Bryant KL; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Edwards AC; Cell Biology and Physiology Curriculum, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Drizyte-Miller K; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Hibshman PS; Cell Biology and Physiology Curriculum, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Diehl JN; Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Lee YS; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Morales AJ; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Taylor KE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Peng S; Illumina, Inc., San Diego, CA 92121, USA., Tran NL; Department of Cancer Biology, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA., Herring LE; Michael Hooker Proteomics Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Prevatte AW; Michael Hooker Proteomics Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Barker NK; Michael Hooker Proteomics Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Hover LD; Monoceros Biosystems LLC, San Diego, CA 92130, USA., Hallin J; Mirati Therapeutics, Inc., San Diego, CA 92121, USA., Sorokin A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kanikarla PM; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chowdhury S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Coker O; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lee HM; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Goodwin CM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Gautam P; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland., Olson P; Mirati Therapeutics, Inc., San Diego, CA 92121, USA., Christensen JG; Mirati Therapeutics, Inc., San Diego, CA 92121, USA., Shen JP; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Graves LM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Lim KH; Division of Medical Oncology, Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO 63110, USA., Wang-Gillam A; Division of Medical Oncology, Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO 63110, USA., Wennerberg K; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark., Cox AD; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Cell Biology and Physiology Curriculum, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Der CJ; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Cell Biology and Physiology Curriculum, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2024 Jun 07; Vol. 384 (6700), pp. eadk0775. Date of Electronic Publication: 2024 Jun 07.
Autor:
Bulanova D; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.; Institute for Molecular Medicine Finland, Helsinki Institute for Life Sciences, University of Helsinki, Helsinki, Finland., Akimov Y; Institute for Molecular Medicine Finland, Helsinki Institute for Life Sciences, University of Helsinki, Helsinki, Finland., Senkowski W; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark., Oikkonen J; Research Program in Systems Oncology (ONCOSYS), University of Helsinki, Helsinki, Finland., Gall-Mas L; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark., Timonen S; Institute for Molecular Medicine Finland, Helsinki Institute for Life Sciences, University of Helsinki, Helsinki, Finland., Elmadani M; Finnish Red Cross Blood Service, Helsinki, Finland., Hynninen J; Department of Obstetrics and Gynecology, Turku University Hospital and University of Turku, Turku, Finland., Hautaniemi S; Research Program in Systems Oncology (ONCOSYS), University of Helsinki, Helsinki, Finland., Aittokallio T; Institute for Molecular Medicine Finland, Helsinki Institute for Life Sciences, University of Helsinki, Helsinki, Finland.; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Oslo Centre for Biostatistics and Epidemiology (OCBE), University of Oslo, Oslo, Norway., Wennerberg K; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
Science advances [Sci Adv] 2024 May 24; Vol. 10 (21), pp. eadj1564. Date of Electronic Publication: 2024 May 23.
Autor:
Adnan Awad S; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; Foundation for the Finnish Cancer Institute, 00290 Helsinki, Finland; Clinical Pathology Department, National Cancer Institute, Cairo University, 11796 Cairo, Egypt. Electronic address: shady.awad@helsinki.fi., Dufva O; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00014 Helsinki, Finland., Klievink J; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland., Karjalainen E; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute for Life Science, University of Helsinki, 00014 Helsinki, Finland., Ianevski A; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute for Life Science, University of Helsinki, 00014 Helsinki, Finland., Pietarinen P; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland., Kim D; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland., Potdar S; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute for Life Science, University of Helsinki, 00014 Helsinki, Finland., Wolf M; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute for Life Science, University of Helsinki, 00014 Helsinki, Finland., Lotfi K; Department of Medical and Health Sciences, Faculty of Medicine and Health, Linköping University, 58183 Linköping, Sweden., Aittokallio T; Foundation for the Finnish Cancer Institute, 00290 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00014 Helsinki, Finland; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute for Life Science, University of Helsinki, 00014 Helsinki, Finland; Institute for Cancer Research, Oslo University Hospital, 0424 Oslo, Norway; Oslo Centre for Biostatistics and Epidemiology, University of Oslo, 0317 Oslo, Norway., Wennerberg K; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute for Life Science, University of Helsinki, 00014 Helsinki, Finland; Biotech Research & Innovation Centre and Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, 2200 Copenhagen, Denmark., Porkka K; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00014 Helsinki, Finland., Mustjoki S; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00014 Helsinki, Finland. Electronic address: satu.mustjoki@helsinki.fi.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2024 May 21; Vol. 5 (5), pp. 101521. Date of Electronic Publication: 2024 Apr 22.
Autor:
Chen Y; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., He L; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., Ianevski A; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., Ayuda-Durán P; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Potdar S; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., Saarela J; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., Miettinen JJ; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., Kytölä S; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Miettinen S; Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Research, Development and Innovation Centre, Tampere University Hospital, Tampere, Finland., Manninen M; Orton Orthopaedic Hospital, Helsinki, Finland., Heckman CA; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Enserink JM; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Wennerberg K; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Aittokallio T; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland. tero.aittokallio@helsinki.fi.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. tero.aittokallio@helsinki.fi.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. tero.aittokallio@helsinki.fi.; Centre for Biostatistics and Epidemiology (OCBE), Faculty of Medicine, University of Oslo, Oslo, Norway. tero.aittokallio@helsinki.fi.
Publikováno v:
Nature protocols [Nat Protoc] 2024 Jan; Vol. 19 (1), pp. 60-82. Date of Electronic Publication: 2023 Nov 23.
Autor:
Ayuda-Durán P; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Hermansen JU; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Giliberto M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Yin Y; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Haematology, Oslo University Hospital, Oslo, Norway., Hanes R; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Gordon S; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Kuusanmäki H; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., Brodersen AM; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Andersen AN; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Taskén K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Wennerberg K; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Enserink JM; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Skånland SS; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. sigrid.skanland@ous-research.no.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. sigrid.skanland@ous-research.no.
Publikováno v:
Cell death discovery [Cell Death Discov] 2023 Dec 01; Vol. 9 (1), pp. 435. Date of Electronic Publication: 2023 Dec 01.
PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells.
Autor:
Denisova OV; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland., Merisaari J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.; Institute of Biomedicine, University of Turku, Finland., Huhtaniemi R; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland., Qiao X; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland., Yetukuri L; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland.; Centre for Biostatistics and Epidemiology (OCBE), University of Oslo, Norway., Jumppanen M; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland., Kaur A; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland., Pääkkönen M; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland., von Schantz-Fant С; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland., Ohlmeyer M; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Atux Iskay LLC, Plainsboro, NJ, USA., Wennerberg K; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland.; Biotech Research & Innovation Centre, University of Copenhagen, Denmark., Kauko O; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland., Koch R; University Medical Center Göttingen, Germany., Aittokallio T; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland.; Centre for Biostatistics and Epidemiology (OCBE), University of Oslo, Norway.; Institute for Cancer Research, Oslo University Hospital, Norway., Taipale M; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Canada., Westermarck J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.; Institute of Biomedicine, University of Turku, Finland.
Publikováno v:
Molecular oncology [Mol Oncol] 2023 Sep; Vol. 17 (9), pp. 1803-1820. Date of Electronic Publication: 2023 Jul 26.